december 2, 2010
PDF 90,8 KB
DownloadForbion Capital Partners co-led Transave's Series B round in December 2002.
Forbion Capital Partners co-led Transave's Series B round in December 2002.
In 2010, the company merged with Insmed Inc. (NASDAQ INSM).
Human Health
Industry
Biotech
Status
Realised
Location
US